1
Clinical Trials associated with NB1000S(Novome Biotechnologies)Phase 1-2a Safety, Tolerability, and Pharmacodynamics Controlled Study of NOV-001 in Healthy Volunteers and Patients With Enteric Hyperoxaluria
The first stage of this study is a prospective, adaptive, Phase 1, first-in-human, randomized, controlled study evaluating safety, tolerability, and pharmacodynamics of NOV-001 in adult healthy volunteers.
The second stage of this study is a prospective, randomized, single-blinded, placebo-controlled study of safety, tolerability, and early efficacy in patients with enteric hyperoxaluria.
100 Clinical Results associated with NB1000S(Novome Biotechnologies)
100 Translational Medicine associated with NB1000S(Novome Biotechnologies)
100 Patents (Medical) associated with NB1000S(Novome Biotechnologies)
100 Deals associated with NB1000S(Novome Biotechnologies)